Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-01

Rhytha Kasiraj

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

2 pubs

Biography and Research Information

OverviewAI-generated summary

Rhytha Kasiraj's research focuses on the comparative analysis of targeted therapies in B-cell malignancies. Their work investigates the real-world outcomes of treatments such as Ibrutinib, Acalabrutinib, and Zanubrutinib, specifically examining mortality and toxicity rates. This research contributes to understanding the comparative effectiveness and safety profiles of these medications in patient populations.

Metrics

  • Publications: 2

Selected Publications

  • POSTER: CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
    Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
  • CLL-1382: Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B-Cell Malignancies: A Real-World Study of Mortality and Toxicity (2026)
    Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

7 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics